This document lists the medicines eligible for supply through the Northern Ireland MHRA Authorised Route (NIMAR).
From 1 January 2022, the listed medicines may be dispatched from Great Britain to Northern Ireland on the basis of the medicines authorisation in Great Britain.
This list is maintained and published in accordance with regulation 167B (list of NIMAR products) of the Human Medicines Regulations 2012 (SI 2012/1916, as amended).
Published 16 December 2021 Last updated 4 November 2022 +show all updates
Added the following medicines to the list: (Trurapi 100 units/ml solution for injection 3ml pre-filled Solostar pens) Insulin aspart 100 units/ml solution for injection 3ml pre-filled disposable devices and Remdesivir 100mg powder for solution for infusion vials. Removed (Truxima 500mg/50ml concentrate for solution for infusion vials) Rituximab 500mg/50ml solution for infusion vials.
Added the following medicine to the list:Reslizumab 100mg/10ml solution for infusion vials;Clopidogrel 300mg tablets;Eltrombopag 75mg tablets;(Remsima 100mg powder for concentrate for solution for infusion vials) Infliximab 100mg powder for solution for infusion vials.Removed the following medicine from the list:Glycopyrronium 44microgram inhalation powder capsules with device;Perampanel 10mg tablets;Perampanel 12mg tablets;Perampanel 2mg tablets;Perampanel 4mg tablets;Perampanel 500micrograms/ml oral suspension sugar free;Perampanel 6mg tablets;Perampanel 8mg tablets;Regadenoson 400micrograms/5ml solution for injection vials.Changed medicines (updated descriptions):Amlodipine/Valsartan 10mg/160mg to Amlodipine/Valsartan 10mg/160mg tablets;Amlodipine/Valsartan 5mg/160mg to Amlodipine/Valsartan 5mg/160mg tablets;Amlodipine/Valsartan 5mg/80mg to Amlodipine/Valsartan 5mg/80mg tablets;Choriogonadotropin to Choriogonadotropin 250micrograms/0.5ml solution for injection pre-filled syringes.
Added the following medicine to the list:Perampanel 500micrograms/ml oral suspension sugar free.
Added the following 16 medicines to the list:Perampanel 2mg tablets;Perampanel 4mg tablets;Perampanel 6mg tablets;Perampanel 8 mg tablets;Perampanel 10mg tablets;Perampanel 12mg tablets;Sodium tetradecyl sulfate 3% solution for injection vials;Sodium tetradecyl sulfate 3% solution for injection ampoules;Sodium tetradecyl sulfate 1% solution for injection ampoules;Sodium tetradecyl sulfate 0.5% solution for injection ampoules;Sodium tetradecyl sulfate 0.2% solution for injection vials;Ovitrelle 250mg/0.5ml solution for injection pre-filled syringes;Choriogonadotropin alfa 250mg/0.5ml solution for injection pre-filled syringes;Dornase alfa 2.5mg nebuliser liquid 2.5ml ampoules; Exenatide 2mg injection;Saxagliptin 2.5mg tablets; andSaxagliptin 5mg tablets.Removed the following 2 medicines from the list: Hemlibra 30mg/1ml solution for injection vials;Emicizumab 30mg/1ml solution for injection vials; andEpirubicin 200mg/100ml solution for infusion vials.
Updated the list to correct a dosage error: changed Secukinumab 300mg/2ml solution for injection pre-filled disposable devices to Secukinumab 150mg/1ml solution for injection pre-filled disposable devices.
Added the following medicines to the list: Bimatoprost 300micrograms/ml eye drops 0.4ml unit dose preservative free; (Truxima 500mg/50ml concentrate for solution for infusion vials) Rituximab 500mg/50ml solution for infusion vials; and Secukinumab 300mg/2ml solution for injection pre-filled disposable devices. Changed Basiliximab 10mg powder and solvent for solution for injection vials (1 vial) to Simulect 10mg powder and solvent for solution for injection vials (1 vial) (brand to generic).
Removed the NutropinAq 10mg/2ml solution for injection cartridges brand name from the following generic medicines:Regadenoson 400micrograms/5ml solution for injection vials;Omalizumab 150mg/1ml solution for injection pre-filled syringes;Fondaparinux sodium 1.5mg/0.3ml solution for injection pre-filled syringes;Simulect 20mg powder and solvent for solution for injection vials;Enfuvirtide 108mg powder and solvent for solution for injection vials;Upadacitinib 45mg modified-release tablets.
Added the following medicines:NutropinAq 10mg/2ml solution for injection cartridges (Enfuvirtide 108mg powder and solvent for solution for injection vials); NutropinAq 10mg/2ml solution for injection cartridges (Fondaparinux sodium 1.5mg/0.3ml solution for injection pre-filled syringes);NutropinAq 10mg/2ml solution for injection cartridges (Omalizumab 150mg/1ml solution for injection pre-filled syringes);NutropinAq 10mg/2ml solution for injection cartridges (Regadenoson 400micrograms/5ml solution for injection vials); NutropinAq 10mg/2ml solution for injection cartridges (Simulect 20mg powder and solvent for solution for injection vials); NutropinAq 10mg/2ml solution for injection cartridges (Somatropin (rbe) 10mg/2ml solution for injection cartridges);NutropinAq 10mg/2ml solution for injection cartridges (Upadacitinib 45mg modified-release tablets).Removed the following
